US 11981716
Activatable interleukin-2 polypeptides and methods of use thereof
granted A61KA61K38/00A61P
Quick answer
US patent 11981716 (Activatable interleukin-2 polypeptides and methods of use thereof) held by Werewolf Therapeutics, Inc. expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Werewolf Therapeutics, Inc.
- Grant date
- Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00